Key facts
- This page summarizes Bihua Chen's Form 4 filing for Biomea Fusion, Inc. (BMEA).
- 0 reported transactions and 5 derivative rows are listed below.
- Accepted by SEC: 01 Aug 2025, 16:05.
Bihua Chen - 01 Aug 2025 Form 4 Insider Report for Biomea Fusion, Inc. (BMEA)
- Reporting relationship
- Former Director
- Issuer ticker
- BMEA
- Reported as of
- 01 Aug 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 01 Aug 2025, 16:05:40 UTC
- Prior SEC filing
- 13 Jun 2025
- Next SEC filing
- 13 Aug 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Bihua Chen
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Bihua Chen filed Form 4 for Biomea Fusion, Inc. (BMEA) on 01 Aug 2025.
Change
- Previous filing in this sequence was filed on 13 Jun 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (4)
CIK 0001599214
Primary reporting owner
Chen Bihua
- Relationship
- Former Director
- Address
- C/O CORMORANT ASSET MANAGEMENT, LP, 200 CLARENDON STREET, 52ND FLOOR, BOSTON
- Signature
- /s/ Bihua Chen
- Signature date
- 01 Aug 2025
CIK 0001618442
Cormorant Global Healthcare Master Fund, LP
- Relationship
- Former 10% Holder
- Address
- 200 CLARENDON STREET, 52ND FLOOR, BOSTON
- Signature
- /s/ CORMORANT GLOBAL HEALTHCARE MASTER FUND, LP, By: Cormorant Global Healthcare GP, LLC, its General Partner By: Bihua Chen, Managing Member
- Signature date
- 01 Aug 2025
CIK 0001817320
Cormorant Private Healthcare Fund III LP
- Relationship
- Former 10% Holder
- Address
- 200 CLARENDON STREET, 52ND FLOOR, BOSTON
- Signature
- /s/ CORMORANT PRIVATE HEALTHCARE FUND III, LP By: Cormorant Private Healthcare GP III, LLC, its General Partner By: Bihua Chen, Managing Member
- Signature date
- 01 Aug 2025
CIK 0001583977
Cormorant Asset Management, LP
- Relationship
- Former 10% Holder
- Address
- 200 CLARENDON STREET, 52ND FLOOR, BOSTON
- Signature
- /s/ CORMORANT ASSET MANAGEMENT, LP By: Cormorant Asset Management GP, LLC, its General Partner, By: Bihua Chen, Managing Member
- Signature date
- 01 Aug 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BMEA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 3,570,872
- Date
- 01 Aug 2025
- Ownership
- See Footnotes
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BMEA
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 28,911
- Date
- 01 Aug 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 28,911
- Exercise price
- $17.00
- Footnotes
- F3, F4
BMEA
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 23,867
- Date
- 01 Aug 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 23,867
- Exercise price
- $10.20
- Footnotes
- F4, F5
BMEA
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 6,989
- Date
- 01 Aug 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 6,989
- Exercise price
- $38.90
- Footnotes
- F4, F5
BMEA
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 51,025
- Date
- 01 Aug 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 51,025
- Exercise price
- $4.63
- Footnotes
- F4, F5
BMEA
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 91,970
- Date
- 01 Aug 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 91,970
- Exercise price
- $2.50
- Footnotes
- F4, F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Bihua Chen is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 5 footnotes
Footnote F1
Shares reported herein are held by Cormorant Global Healthcare Master Fund, LP (the "Master Fund"), Cormorant Private Healthcare Fund III, LP (the "Fund III"), and a managed account (the "Account"). Cormorant Asset Management, LP ("Cormorant") serves as the investment manager of the Master Fund, Fund III, and the Account. Bihua Chen serves as manager of the general partner of Cormorant. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose.
Footnote F2
Represents (i) 1,795,928 shares of Common Stock held by the Master Fund, (ii) 1,717,232 shares of Common Stock held by Fund III, and (iii) 57,712 shares of Common Stock held by the Account.
Footnote F3
The options were granted with a 36 month vesting period, vesting monthly.
Footnote F4
Stock options granted to Bihua Chen, in her capacity as a director of the Issuer.
Footnote F5
The options vest in full upon the earlier of (i) the one-year anniversary of the date of grant or (ii) immediately prior to the annual meeting of the Issuer's stockholders that occurs following the date of grant, subject to Ms. Chen's continuing service to the Issuer through such vesting date.
SEC remarks
Bihua Chen resigned as a director of the Issuer as of July 22, 2025. As a result, and in light of the fact that none of the reporting persons beneficially owns over 10% of the outstanding shares of Common Stock of the Issuer, the reporting persons no longer intend to report transactions in such securities on Form 4 or Form 5.